CO89 Integrated Analysis of Efficacy and ICU Length of Stay Data From Phase 2 and Phase 3 Trials of Rezafungin for the Treatment of Invasive Candidiasis and/or Candidemia
Bielicka, I, Dickerson, S, Manamley, N, Das, A, Sandison, T
Published in Value in health (01.12.2022)
Published in Value in health (01.12.2022)
Get full text
Journal Article
POSC9 Early Response in the Treatment of Invasive Candida Disease, Length of Stay on the Intensive Care Unit and Projected Costs with Once-Weekly Rezafungin Antifungal Therapy
Bielicka, I, Dickerson, S, Kenworthy, J, Das, A, Sandison, T
Published in Value in health (01.01.2022)
Published in Value in health (01.01.2022)
Get full text
Journal Article
EE333 Cost-Effectiveness of Once-Weekly Rezafungin for the Treatment of Candidemia and Invasive Candidiasis in the UK
Muszbek, N., Angdembe, A., Garcia-Vidal, C., Bielicka, I., Abrams, K., Tolley, K., Ruhnke, M., Lebmeier, M., Hawkins, N., Manamley, N., Dickerson, S.
Published in Value in health (01.12.2023)
Published in Value in health (01.12.2023)
Get full text
Journal Article